| ²é¿´: 269 | »Ø¸´: 9 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
¸÷λ¸ßÊÖÇë½ø
|
|||
The active substance manufacturer's restricted ("closed" part of the EDMF should follow thestructure of Module 3.2.S of the CTD. A separate Quality Overall Summary for the information included in the active substance manufacturer's restricted ("closed" part shouldalso be provided, as part of the EDMF. ÕâÒ»¶ÎÊDz»ÊÇ˵Ã÷CTDÖÐÖÁÉÙÊÇÅ·ÖÞµÄÖÆ¼ÁÉ걨,³ýÁËÊÚȨÐÅÒÔÍâ,»¹ÊÇÐèÒªÔÁÏÒ©DMFµÄ¹«¿ª²¿·ÖÎļþºÍ·Ç¹«¿ª²¿·ÖÎļþÁ˰¡,²»ÊÇ˵²»Ó÷ǹ«¿ªµÄ²¿·ÖÂð, |
» ²ÂÄãϲ»¶
ÇóÖúhttps://www.pnas.org/doi/10.1073/pnas.2535777123 È«ÎÄ
ÒѾÓÐ0È˻ظ´
¶à¾Û×é°±Ëᣬ´ó·Ö×ÓÁ¿
ÒѾÓÐ20È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ88È˻ظ´
ÒȵºËصÄʵÑéÊÒ±í´ï
ÒѾÓÐ0È˻ظ´
ÒȵºËصÄʵÑéÊÒ±í´ï
ÒѾÓÐ0È˻ظ´
ÒȵºËصÄʵÑéÊÒ±í´ï
ÒѾÓÐ0È˻ظ´
ÒȵºËصÄʵÑéÊÒ±í´ï
ÒѾÓÐ1È˻ظ´
ÒȵºËصÄʵÑéÊÒ±í´ï
ÒѾÓÐ0È˻ظ´
ÒȵºËصÄʵÑéÊÒ±í´ï
ÒѾÓÐ0È˻ظ´
ÇóÖúµç×Ӱ棺¾§ÐÍÒ©ÎïÑз¢ÀíÂÛÓëÓ¦ÓÃ
ÒѾÓÐ0È˻ظ´
zhoudingcheng
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 6594.2
- Ìû×Ó: 334
- ÔÚÏß: 61.7Сʱ
- ³æºÅ: 117382
- ×¢²á: 2005-11-26
- רҵ: Óлú·ÖÎö

5Â¥2007-03-05 12:46:16
2Â¥2007-03-04 19:00:57
3Â¥2007-03-04 19:01:12
4Â¥2007-03-05 09:21:36











part of the EDMF should follow the
»Ø¸´´ËÂ¥
10